News

This week, both Duke University and the School of Medicine took steps to acknowledge and address systemic racism, both within their institutions and across the nation, with particular emphasis on t

This week’s “spotlight” interview shines on Safa Kaleem, a rising fourth-year medical student at the Duke University School of Medicine, as well as a recent graduate of the School’s Clinical Re

Ornit Chiba-Falek, PhD, and Simon Davis, PhD, both recently received new grants for multidisciplinary research to advance our understanding of Alzhiemer’s disease.

Ariel Lefland, MD, has been drawn to neurology for as long as she can remember.

James Camp, MSN, likes to think of himself as the Moriarty of Duke University Hospital’s neuro Intensive Care Unit (ICU), where he works behind the scenes, plotting ways to improve safety, inno

In May 2020, members of the Duke Neurology Department contributed to nine new peer-reviewed journal articles.

Dozens of behind-the-scenes financial consequences and questions result from even the simplest of clinic visits to one of our neurologists.

When facing an illness such as ALS, one in which there currently is no proven treatment to stop or reverse it, patients often look to clinical trials for options for living longer and better lives.

Nicole Calakos, MD, PhD, and Al La Spada, MD, PhD, have been awarded distinguished professorships from Duke University.

While radiation and chemotherapy treatments for brain cancer can help shrink tumors, they can also lead to neurocognitive limitations that severely affect a patient’s quality of life.